WHO Lists Pfizer/BioNTech Vaccine as First Best Emergency Use

Суббота, 02 Янв, 2021

Both vaccines have shown high levels off effectiveness agains the vaccine, but the Pfizer vaccine - which was given emergency approval by the FDA weeks before the Moderna vaccine was - requires specialized refrigeration equipment to store at ultra-cold temperatures.

Despite a slow start to US vaccinations, there was good news overseas this week as the United Kingdom gave emergency-use authorization to the COVID-19 vaccine produced by AstraZeneca and the University of Oxford.

Meanwhile, the USA continues to stumble through the pandemic as thousands die every day. She said the county public health office is not now keeping a list, but they do plan on utilizing the Code Red emergency notification system to let people know about vaccine availability, locations, dates and times, along with utilizing all forms of media to get the word out.

The European Medicines Agency (EMA) is expected to approve a vaccine by pharma company Moderna on January 6, while German Health Minister Jens Spahn has also urged the EMA to quickly approve a vaccine developed by Oxford University and AstraZeneca that the United Kingdom cleared this week. "This is going to be the greatest operational challenge we've ever faced as a nation".

Scott Gottlieb, the former head of the U.S. Food and Drug Administration and Pfizer board member, told USA Today earlier this month, "I feel very strongly that we should get as many shots in arms as possible, right away".

"The Major General says Canadian authorities have already received the first 168,000 doses of Moderna, and they will all be delivered this week". In addition, it is easier to use and much cheaper than Pfizer-BioNTech.

People queue at an NHS Covid-19 vaccination centre for the Pfizer-BioNTech COVID-19 vaccine in London.

UK Prime Minister Boris Johnson has labeled the news a "triumph" and says healthcare workers will begin vaccinating people "as quickly as possible".

When patients were given two full shots, the vaccine was 62% effective - less than the Pfizer-BioNTech shot and another from Moderna Inc. It requires two doses, administered three weeks apart. The bulk of Moderna vaccines are not expected to arrive until March.

Britain, hard hit by a worrisome new strain of the virus and now divorced from the European Union, again gave its green light first.

A researcher in a laboratory at the Jenner Institute at the University of Oxford in England works on the coronavirus vaccine developed by AstraZeneca and Oxford University in this undated photo.

Instead, a spokesman said that the MHRA, the regulator which recently approved the AstraZeneca vaccine, "set out conditions with their authorisation on 30 December and batch testing is taking place to ensure the vaccines consistently meet these strict requirements". "We will be producing around 300 million doses by July 2021", he added.

All the evidence suggests the number falls well short of the 40 million doses of both vaccines that we were originally supposed to have by this stage.